Pipeline

 

 

 

PC = Pre-Clinical; P1=Phase I; P2=Phase II, P3=Phase III; RF=Regulatory Filing & Approval

 

Oncology

PC P1 P2 P3 RF
           

ABRAXANE® (nanoparticle albumin-bound paclitaxel)

Breast: Metastatic logo logo logo logo logo
Breast: Early (neoadjuvant) logo logo logo logo  
Breast: Metastatic (triple negative, 1st-line) + carboplatin logo logo logo logo  
Breast: Metastatic (triple negative, 1st-line) + atezolizumab logo logo logo logo  
Breast: Early (triple negative, 1st-line) + carboplatin + atezolizumab logo logo logo logo  
Breast: Early (triple negative) + pembrolizumab logo logo      
Breast: Advanced (triple negative, 1st-line) + durvalumab +tremelimumab logo logo      
Breast: Metastatic (HER2-negative) + nivolumab logo logo      
Lung: Advanced NSCLC (1st-line) + carboplatin logo logo logo logo logo
Lung: Adv Squamous NSCLC (1st-line) + carboplatin + atezolizumab logo logo logo logo  
Lung: Adv Non-squamous NSCLC (1st-line)+ carboplatin + atezolizumab logo logo logo logo  
Melanoma: Metastatic logo logo logo logo  
Pancreatic: Metastatic (1st-line) + gemcitabine logo logo logo logo logo
Pancreatic: Adjuvant + gemcitabine logo logo logo logo  

NERLYNX® (neratinib)

HER2+ Early Breast Cancer (extended adjuvant) logo logo logo logo logo
HER2+ Early Breast Cancer (loperamide prophylaxis) logo logo logo    
HER2+ Metastatic Breast Cancer (combination with T-DM1) logo logo logo    
HER2+ Metastatic Breast Cancer (1st line) logo logo logo    
HER2+ Metastatic Breast Cancer (3rd line) logo logo logo logo  
Metastatic Breast Cancer with Brain Metastases logo logo logo    
Early Breast Cancer (neoadjuvant) I-SPY 2 logo logo logo    
Early Breast Cancer (neoadjuvant) logo logo logo    
Solid Tumours with EGFR mutations (basket trial) logo logo logo    
Metastatic Breast Cancer (HER2 non-amplified, HER2 mutant) logo logo logo    

ZEPZELCA™ (lurbinectedin)

         
Small Cell Lung Cancer (SCLC) logo logo logo logo  
BRCA 1/2 Breast Cancer logo logo logo    
Cancer - Basket Trial logo logo logo    
Mesothelioma logo logo logo logo  

YONDELIS® (trabectedin)

         
Leiomyosarcoma and Liposarcoma logo logo logo logo logo

GLIOLAN® (aminolevulinic acid HCl)

         
Visualisation during surgery for malignant glioma logo logo logo logo logo

QINLOCK® (ripretinib)

         
INVICTUS Study logo logo logo logo  
INTRIGUE Study logo logo logo logo  

Oncotype DX®

         
Breast Cancer Assay logo logo logo logo logo
DCIS Assay logo logo logo logo logo
Colon Cancer Assay logo logo logo logo logo
Prostate Cancer Assay logo logo logo logo logo

Haematology

PC P1 P2 P3 RF
           

APLIDIN® (plitidepsin)

         
Refractory / relapsed multiple myeloma logo logo logo logo logo
Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma logo logo logo    
Relapsed/Refractory Multiple Myeloma (with bortezomib) logo logo logo    

rigosertib

         
High-Risk Myelodysplastic Syndrome (MDS) (2nd line IV) logo logo logo logo  
High-Risk Myelodysplastic Syndrome (MDS) (1st line oral) logo logo logo    

Supportive Care

PC P1 P2 P3 RF
           

anamorelin

         
Cancer anorexia-cachexia in NSCLC patients logo logo logo logo  

Ophthalmology

PC P1 P2 P3 RF
           

ILUVIEN® (fluocinolone acetonide intravitreal implant)

Diabetic macular oedema logo logo logo logo logo

 

To learn more about the clinical trials that are underway and to find out if a study is enrolling patients in your area, please visit www.clinicaltrials.gov